Bladder cancer
New hope for patients progressing after prior treatment for mUCa

Magnus (76 years old)

Magnus is a 76-year-old retired firefighter. He has a history of chronic kidney disease associated with hypertension. He initially presented with UCa of the bladder with metastases in the lungs and was treated with gemcitabine + carboplatin. After 6 cycles of chemotherapy, he has now progressive disease.

Assessment summary:

  • ECOG PS: 2
  • No peripheral neuropathy
  • No hearing impairment
  • GFR: 35 ml/min
  • Haemoglobin: 9.8 g/dl
  • CT scan reveals worsening of lung and new liver metastases
  • FGFR2/3 mutation status in diagnostic biopsy specimen: activating FGFR3 mutation

Which of the following treatment options would you choose for this patient?